Warnings
Xanax Očekivano Mefedron. Otkriveno 2-MMC, Ketamin. Lokacija: Zürich, Švicarska. Datum: 2025-07-08. Izvor: saferparty.ch.
Tableta Xanax — Zürich, Švicarska — 2025-07-08
Detected 2-MMC, Ketamine
Expected 4-MMC
Logo Xanax
Color grey
Location Zürich, Switzerland
Date 2025-07-08
Source saferparty.ch
Media 1 image Appearance Logo: Xanax Color: grey Media: 1 sample photo Expected vs Detected 4-MMC
Detected result: 2-MMC, Ketamine
Sample Details No additional sample descriptors available.
Testing Context Location: Zürich, Švicarska Date tested: 2025-07-08 Source: saferparty.ch Harm Reduction Similar-looking pills can contain different substances or strengths. Use drug checking services when available. Start low and avoid assuming a logo identifies the contents. SampleDNA Beta 2358 povezanih upozorenja · Saznajte više o uobičajenim nečistoćama.
2-MMC Otkriveno Ketamine Otkriveno Povezani uzorci i kombinacije
2-MMC + Ketamine
30 uzoraka · Trenutni rezultat
Otkriveno zajedno u povezanim rezultatima provjere droga.
Xanax logo
213 uzoraka · Trenutni rezultat
Isti se logo pojavljuje u povezanim rezultatima provjere droga.
Medetomidine
Xanax · Graz, Austrija · 2026-10-23
Flualprazolam
Xanax, 2 · Vienna, Austrija · 2026-08-24
Methylclonazepam
Xanax · Powys (LD3), Wales · 2026-07-23
Alprazolam
Xanax · Kensington and Chelsea, Wandsworth, Westminster (SW1W), England · 2026-07-23
Bromazolam
Xanax · Argyll and Bute, West Dunbartonshire (G82), Ujedinjeno Kraljevstvo · 2026-07-16
Alprazolam
Xanax · City of Edinburgh, Midlothian (EH10), Ujedinjeno Kraljevstvo · 2026-07-16
2-MMC + 4-MMC + Ketamine
2 uzorka
Otkriveno zajedno u povezanim rezultatima provjere droga.
2-MMC + 2C-B + Ketamine + MDMA + Unknown
1 uzorak
Otkriveno zajedno u povezanim rezultatima provjere droga.
2-MMC + 3-CMC + Caffeine + Cocaine + iso-LSD + Ketamine + LSD + MDMA + Methylone + Tetramisole
1 uzorak
Otkriveno zajedno u povezanim rezultatima provjere droga.
Istraživač SampleDNA
Links This static page is intended as the readable export baseline for crawler and low-capability delivery.